Mutations of thyrotropin receptor isolated from thyroid autonomous functioning adenomas confer TSH-independent growth to thyroid cells

被引:16
作者
Porcellini, A
Ruggiano, G
Pannain, S
Ciullo, I
Amabile, G
Fenzi, G
Avvedimento, EV
机构
[1] UNIV REGGIO CALABRIA,FAC MED,DIPARTIMENTO MED SPERIMENTALE,I-88100 CATANZARO,ITALY
[2] FDN G PASCALE,SERV ONCOL SPERIMENTALE E,IST NAZL TUMORI,I-80131 NAPLES,ITALY
[3] UNIV NAPLES FEDERICO II,FAC MED,CTR ENDOCRINOL & ONCOL SPERIMENTALE,I-80131 NAPLES,ITALY
[4] UNIV NAPLES FEDERICO II,FAC MED,DIPARTIMENTO BIOL & PATOL MOL & CELLULARE L CALIF,I-80131 NAPLES,ITALY
[5] UNIV NAPLES FEDERICO II,FAC MED,DEPT ENDOCRINOL,I-80131 NAPLES,ITALY
关键词
thyrotropin receptor; mutations; cAMP signaling; neoplasm; genetics;
D O I
10.1038/sj.onc.1201240
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
TSH receptor mutants in the VI transmembrane segment, found in thyroid autonomously functioning adeonomas, have been expressed in differentiated thyroid cells, All mutant receptors constitutively stimulated adenylyl cyclase, The biological activity, measured as cAMP production relative to the wild type receptor, was specific for each mutant in transient and stable transfection assays. Cells expressing these mutants proliferated in the absence of TSH, The rate of growth in the absence of TSH paralleled basal cAMP production for each mutant receptor, Low TSH concentrations stimulated of mutant receptor-expressing growth of the cells expressing the wild type receptor, Also, the entry in the cell cycle and the plating efficiency were markedly stimulated by the expression of the mutant receptors, These data provide a molecular link between the occurrence of TSH receptor mutations and thyroid autonomously functioning adenomas.
引用
收藏
页码:781 / 789
页数:9
相关论文
共 32 条
[11]  
COTECCHIA S, 1990, J BIOL CHEM, V265, P63
[12]   V-RAS AND PROTEIN-KINASE-C DEDIFFERENTIATE THYROID-CELLS BY DOWN-REGULATING NUCLEAR CAMP-DEPENDENT PROTEIN KINASE-A [J].
GALLO, A ;
BENUSIGLIO, E ;
BONAPACE, IM ;
FELICIELLO, A ;
CASSANO, S ;
GARBI, C ;
MUSTI, AM ;
GOTTESMAN, ME ;
AVVEDIMENTO, EV .
GENES & DEVELOPMENT, 1992, 6 (09) :1621-1630
[13]   HIGH-EFFICIENCY DNA-MEDIATED TRANSFORMATION OF PRIMATE CELLS [J].
GORMAN, C ;
PADMANABHAN, R ;
HOWARD, BH .
SCIENCE, 1983, 221 (4610) :551-553
[14]   EVIDENCE THAT ADENOSINE-3',5'-MONOPHOSPHATE MEDIATES STIMULATION OF THYROID GROWTH IN FRTL5 CELLS [J].
JIN, S ;
HORNICEK, FJ ;
NEYLAN, D ;
ZAKARIJA, M ;
MCKENZIE, JM .
ENDOCRINOLOGY, 1986, 119 (02) :802-810
[15]   BRIEF REPORT - CONGENITAL HYPERTHYROIDISM CAUSED BY A MUTATION IN THE THYROTROPIN-RECEPTOR GENE [J].
KOPP, P ;
VANSANDE, J ;
PARMA, J ;
DUPREZ, L ;
GERBER, H ;
JOSS, E ;
JAMESON, JL ;
DUMONT, JE ;
VASSART, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (03) :150-154
[16]   G-PROTEIN-COUPLED RECEPTORS - TURNED ON TO ILL EFFECT [J].
LEFKOWITZ, RJ .
NATURE, 1993, 365 (6447) :603-604
[17]   2 G-PROTEIN ONCOGENES IN HUMAN ENDOCRINE TUMORS [J].
LYONS, J ;
LANDIS, CA ;
HARSH, G ;
VALLAR, L ;
GRUNEWALD, K ;
FEICHTINGER, H ;
DUH, QY ;
CLARK, OH ;
KAWASAKI, E ;
BOURNE, HR ;
MCCORMICK, F .
SCIENCE, 1990, 249 (4969) :655-659
[18]   ACTIVATION OF THE CYCLIC-AMP CASCADE AS AN ONCOGENIC MECHANISM - THE THYROID EXAMPLE [J].
MAENHAUT, C ;
ROGER, PP ;
REUSE, S ;
DUMONT, JE .
BIOCHIMIE, 1991, 73 (01) :29-36
[19]   ACTIVATING POINT MUTATIONS OF THE GSP ONCOGENE IN HUMAN THYROID ADENOMAS [J].
OSULLIVAN, C ;
BARTON, CM ;
STADDON, SL ;
BROWN, CL ;
LEMOINE, NR .
MOLECULAR CARCINOGENESIS, 1991, 4 (05) :345-349
[20]   SOMATIC MUTATIONS CAUSING CONSTITUTIVE ACTIVITY OF THE THYROTROPIN RECEPTOR ARE THE MAJOR CAUSE OF HYPERFUNCTIONING THYROID ADENOMAS - IDENTIFICATION OF ADDITIONAL MUTATIONS ACTIVATING BOTH THE CYCLIC ADENOSINE-3',5'-MONOPHOSPHATE AND INOSITOL PHOSPHATE-CA2+ CASCADES [J].
PARMA, J ;
VANSANDE, J ;
SWILLENS, S ;
TONACCHERA, M ;
DUMONT, J ;
VASSART, G .
MOLECULAR ENDOCRINOLOGY, 1995, 9 (06) :725-733